Mol Nutr Food Res. 2005 May;49(5):462-71.

Resveratrol and breast cancer chemoprevention: molecular mechanisms.

Le Corre L, Chalabi N, Delort L, Bignon YJ, Bernard-Gallon DJ.

Source

Laboratoire d'Oncologie Moléculaire, CBRV, Centre Jean Perrin, Clermont-Ferrand, France.

Abstract

Despite years of intensive research, breast cancer remains a major cause of death among women. New strategies to combat breast cancer are being developed, one of the most exciting of which is the use of chemopreventive agents. Resveratrol (RES) is a polyphenolic compound found in plants that seems to have a wide spectrum of biological activity. RES has been shown to afford protection against several types of cancer. This review summarizes the chemopreventive effects of RES at the three major stages of breast carcinogenesis: initiation, promotion, and progression. It has anti-oxidant and anti-inflammatory properties, and may induce apoptosis as well as modulate cell cycle and estrogen receptor function in breast cancer cell lines. Although RES has shown remarkable promise as a potent chemopreventive agent in breast cancer, further studies are needed to etablish its usefulness.

PMID:: 15786518; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Breast Cancer - MedlinePlus Health Information

Molecular Biology Databases

RESVERATROL - HSDB

Supplemental Content

Save items

Related citations in PubMed

Review Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. [Mol Nutr Food Res. 2005]
Review Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis.
Ulrich S, Wolter F, Stein JM. Mol Nutr Food Res. 2005 May; 49(5):452-61.
Review Resveratrol--a prostate cancer chemopreventive agent? [Urol Oncol. 2002]
Review Resveratrol--a prostate cancer chemopreventive agent?
Ratan HL, Steward WP, Gescher AJ, Mellon JK. Urol Oncol. 2002 Nov-Dec; 7(6):223-7.
Review Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. [Cancer Lett. 2008]
Review Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives.
Kundu JK, Surh YJ. Cancer Lett. 2008 Oct 8; 269(2):243-61. Epub 2008 Jun 11.
Review Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. [J Nutr Biochem. 2005]
Review Resveratrol as an anticancer nutrient: molecular basis, open questions and promises.
Signorelli P, Ghidoni R. J Nutr Biochem. 2005 Aug; 16(8):449-66.
Review Resveratrol and chemoprevention. [Cancer Lett. 2009]
Review Resveratrol and chemoprevention.
Goswami SK, Das DK. Cancer Lett. 2009 Oct 18; 284(1):1-6. Epub 2009 Mar 3.

See reviews... See all...

Cited by 17 PubMed Central articles

The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow. [Neoplasia. 2011]
The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow.
Kirabo A, Park SO, Majumder A, Gali M, Reinhard MK, Wamsley HL, Zhao ZJ, Cogle CR, Bisht KS, Keserü GM, et al. Neoplasia. 2011 Nov; 13(11):1058-68.
Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines. [PLoS One. 2011]
Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines.
Hussain AR, Uddin S, Bu R, Khan OS, Ahmed SO, Ahmed M, Al-Kuraya KS. PLoS One. 2011; 6(9):e24703. Epub 2011 Sep 12.
Resveratrol, MicroRNAs, Inflammation, and Cancer. [J Nucleic Acids. 2011]
Resveratrol, MicroRNAs, Inflammation, and Cancer.
Tili E, Michaille JJ. J Nucleic Acids. 2011; 2011:102431. Epub 2011 Aug 10.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Resveratrol and breast cancer chemoprevention: molecular mechanisms.
Resveratrol and breast cancer chemoprevention: molecular mechanisms.
Mol Nutr Food Res. 2005 May ;49(5):462-71.

PubMed
Genetic polymorphisms: impact on the risk of fetal alcohol spectrum disorders.
Genetic polymorphisms: impact on the risk of fetal alcohol spectrum disorders.
Birth Defects Res A Clin Mol Teratol. 2005 Apr ;73(4):195-203.

PubMed
Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurol...
Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease.
Ann Neurol. 2005 Apr ;57(4):526-34.

PubMed
[Water quality cuts down the chronic inflammatory risk: how to obtain it and kee...
[Water quality cuts down the chronic inflammatory risk: how to obtain it and keep it over time].
G Ital Nefrol. 2005 Jan-Feb ;22 Suppl 31:S70-4.

PubMed
Patient attitudes to sternotomy and thoracotomy scars.
Patient attitudes to sternotomy and thoracotomy scars.
Thorac Cardiovasc Surg. 2005 Apr ;53(2):93-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Resveratrol and breast cancer chemoprevention: molecular mechanisms.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 17 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information